Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients

Bibliographic description

punktacja MEiN [2016 A]: 35

title:	Preclinical pharmacokinetics, biodistribution, radiation dosimetry and toxicity studies required for regulatory approval of a phase I clinical trial with 111In-CP04 in medullary thyroid carcinoma patients
author:	Maina Theodosia, Konijnenbergb Mark W., KolencPeitl Petra, Garnuszek Piotr, Nock Berthold A., Kaloudi Aikaterini, Kroselj Marko, Zaletel Katja, Maecke Helmut, Mansi Rosalba, Erba Paola, von Guggenberg Elisabeth, Hubalewska-Dydejczyk Alicja , Mikołajczak Renata, Decristoforo Clemens
journal title:	European Journal of Pharmaceutical Sciences
volume:	91
date of publication :	2016
pages:	236-242
ISSN:	0928-0987
eISSN:	1879-0720
DOI:	10.1016/j.ejps.2016.05.011
language:	English
journal language:	English
departmental parameterization:	35
affiliation:	Wydział Lekarski : Klinika Endokrynologii
type:	journal article
subtype:	academic paper